Photo from wikipedia
It is very strange that Traboulsee et al.1 did not publish any MRI data; this does not allow a meta-analysis comparison with other trials. The Brave Dreams trial2 examined patients… Click to show full abstract
It is very strange that Traboulsee et al.1 did not publish any MRI data; this does not allow a meta-analysis comparison with other trials. The Brave Dreams trial2 examined patients with relapsing-remitting MS (RRMS) undergoing percutaneous transluminal angioplasty (PTA) for chronic cerebrospinal venous insufficiency, and this Canadian study contains a mixed population of RRMS and secondary-progressive MS.1 Furthermore, a population with a mean age of 50 years and a disease duration of 17 years is not an acceptable study group for PTA
Keywords:
randomized double;
efficacy venoplasty;
response safety;
reader response;
venoplasty randomized;
safety efficacy
Journal Title: Neurology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Neurology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!